Pharmaceutical, Pills Source: TFP File Photo

Louisiana Doctor Sentenced To Over 7 Years For Illegal Opioid Distribution, Healthcare Fraud

Pharmaceutical, Pills Source: TFP File Photo
Pharmaceutical, Pills Source: TFP File Photo

A Louisiana physician has been sentenced to 87 months (over 7 years) in federal prison for conspiring to illegally distribute large quantities of opioids and defrauding healthcare programs of millions of dollars.

Adrian Dexter Talbot, M.D., 59, of Slidell, was sentenced following his conviction in July 2024 on charges of conspiracy to distribute controlled substances, unlawful distribution of controlled substances, maintaining a drug-involved premises, and conspiracy to commit healthcare fraud.

READ: Deputies And Fire Rescue In Florida Team Up For Dramatic Lake Rescue

Talbot owned and operated Medex Clinical Consultants, a medical clinic in Slidell. Evidence presented at trial showed that Talbot routinely prescribed Schedule II controlled substances, including oxycodone, hydrocodone, and morphine, to individuals without proper examinations or medical necessity.

He even pre-signed prescriptions for patients he did not see, and hired another practitioner to do the same, in exchange for cash payments. Talbot also falsified patient records to conceal the scheme.

READ: Fatal Crash Claims One Life, Injures Adult And 6 Children In St. Petersburg

These actions resulted in fraudulent billing to healthcare programs, including Medicare, Medicaid, and Blue Cross Blue Shield of Louisiana, totaling over $5.4 million.

The investigation and prosecution of this case involved multiple agencies, including the Department of Justice, HHS-OIG, VA-OIG, FBI, and the Louisiana Medicaid Fraud Control Unit.

Please make a small donation to the Tampa Free Press to help sustain independent journalism. Your contribution enables us to continue delivering high-quality, local, and national news coverage.

Connect with us: Follow the Tampa Free Press on Facebook and Twitter for breaking news and updates.

Sign up: Subscribe to our free newsletter for a curated selection of top stories delivered straight to your inbox.

Login To Facebook To Comment